n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Friday, October 20th, 2017

The QualityStocks
Daily Stock List

graphic
graphic

PwrCor, Inc. (PWCO)

InvestorsHub, MarketWatch, OTC Markets, Amigo Bulls, Stockhouse, Barchart, and Stockopedia reported on PwrCor, Inc. (PWCO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

PwrCor, Inc is a clean technology energy technology company. It is launching advanced and disruptive solutions for the Waste Heat to Energy, Geothermal, and Solar Thermal markets, as well as other applicable markets. PwrCor also focuses on energy infrastructure development projects and delivering cleantech energy solutions to commercial and not-for-profit customers. PwrCor has its headquarters in New York, New York. The Company’s shares trade on the OTC Markets Group’s OTCQB.

PwrCor also identifies, selects, and implements cost-effective and sustainable energy production technologies for its customers. The Company assists in varied ways to finance those improvements. The PwrCor™ engines utilize proprietary technology that can cost effectively convert ultra-low-grade heat to usable mechanical or electrical energy.

PwrCor™ uses no fossil fuels and does not operate via combustion. It has no emissions, and does not process any working fluids that are flammable, harmful to the environment, or expensive to replace.  PwrCor™ is scalable and modular. Moreover, it runs relatively silently, all within a small footprint.

PwrCor has started a program with Consolidated Edison, Inc. to develop a pilot project based on its proprietary PwrCor™ engine technology. This program is based on PwrCor’s advanced green waste-heat-to-power technology in an application that captures waste steam condensate and converts it to electricity before it is disposed of in the municipal sewer system.

Consolidated Edison (Con Ed)   is one of the largest publicly owned energy companies in the U.S. The structure of the program is to culminate in a Pilot Project installation of a PwrCor engine at a suitable Con Ed customer site.

PwrCor’s proprietary technology captures the steam condensate (hot water) before it is disposed of. This technology can deliver electric power to the building. In addition, because of the process, it cools the hot water, eliminating the need to buy water to temper the over-hot condensate before it can be disposed of in the sewer system.

The Company’s proprietary technology can operate in the entire range of temperatures. However, PwrCor expects to quickly capture market share through expanding the market into lower temperature resources. The Company can make a customer’s power generation more efficient. PwrCor can help them tap renewable energy sources, therefore qualifying them as providing renewable energy.

The Company’s executive team combines years of practical experience with alternative energy technology and solutions with years of experience and a notable record of accomplishment in successful energy project development. PwrCor has access to proprietary technology; it also works to select the best appropriate technology for any particular application. PwrCor has a bias towards applying “green” or environmentally benign technologies and alternative energy solutions.

PwrCor, Inc. (PWCO), closed Friday's trading session at $0.255, up 2.43%, on 366,201 volume with 43 trades. The average volume for the last 60 days is 51,044 and the stock's 52-week low/high is $0.01/$0.45.

U-Vend, Inc. (UVND)

OTCMagic, Stocks To Watch, Penny Stock Beats, MyBestStockAlerts, PennyStockInformer, PennyStockLaboratory, Stock Commander, ProTrader, StockRockandRoll, SmallCapVoice, PennyStockLocks, MicroCapDaily, Winston Small Cap, OTPicks, and PennyStocks24 reported earlier on U-Vend, Inc. (UVND), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

U-Vend, Inc. is a consumer products and automated retailing enterprise. The Company creates, markets, and sells innovative ice cream and related food products. These products undergo distribution to retail markets utilizing diverse next-generation self-serve electronic kiosks across North America. U-Vend owns and operates these kiosks.

Established in 2009, U-Vend is based in Santa Monica, California. In addition, the OTCQB-listed Company has offices in Orange, California; and Las Vegas, Nevada. U-Vend USA LLC established in April of 2010.

The Company develops, distributes, and markets next-generation self-serve electronic kiosks and merchandisers with a digital advertising component. U-Vend has partnered with many national consumer product companies to deliver new and innovative customer retail experiences in automated frictionless settings.

U-Vend’s customer base consists of retail installations, co-branding partnerships, direct sales, and the general population wanting to own their own business. U-Vend end-users include national chains, independent owner operators, big box stores, restaurants, malls, airports, casinos, universities, and colleges, among others. U-Vend offers low-cost investment with the potential for high returns.

U-Vend has four market segments: Environmental, Retail, Service, and Mall/Airport Islands. The Company’s emphasis is Environmental and Retail. It has designed a Mall and Airport Multipurpose Island.

U-Vend took many of its Self-Serve kiosks and bundled them into an "island", all in one central location. This has created a destination concept within a mall and/or airport setting. The island is always associated with a co-branding anchor as part of the total concept.

U-Vend kiosks, in some cases, are wireless, managed on line 24/7, and accept credit and debit cards. In Retail kiosks, a touch screen catalogue is provided for customers to scroll through and review all products being provided in the kiosk.

Recently, U-Vend announced that international consumer and durable goods business executive Ms. Pamela Evans joined the Company’s Board of Directors. She is the Founder and President of Evans Consulting Group. This is a strategic business consulting firm headquartered in Cleveland, Ohio.

Ms. Evans expertise is in business strategy, marketing, as well as sales. She brings acquisition experience from her tenure at Eveready Battery Company, Union Carbide Corporation (now Dow Chemical), and launching new ventures at Sentry Safe and Esselte Pendaflex Corporation.

Last week, U-Vend announced that it entered into a contract manufacturing agreement with The Ice Cream Exchange. This agreement is to develop, produce, and package, its soon-to-be released national sports-themed ice cream products.

The Ice Cream Exchange presently produces a broad array of ice cream desserts, bulk ice creams, sorbets, frozen yogurts, and gelatos for Whole Foods and other major grocery and chain store retailers. The Ice Cream Exchange has production capabilities to support 20,000,000 ice cream units for U-Vend annually.

U-Vend, Inc. (UVND), closed Friday's trading session at $0.026, down 34.84%, on 4,093 volume with 5 trades. The average volume for the last 60 days is 14,461 and the stock's 52-week low/high is $0.0151/$0.06.

NRG Metals, Inc. (NRGMF)

MarketWatch, Barchart, Stockhouse, The Street, and 4-Traders reported on NRG Metals, Inc. (NRGMF) and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, NRG Metals, Inc. is a Junior Canadian Exploration Company headquartered in Vancouver, British Columbia. It searches for brine-based lithium targets in Argentina, Bolivia, and Chile. The Company has positioned itself for fast growth in the brines of South America. NRG Metals is operating in miner-friendly jurisdictions with first-rate infrastructure, targeting battery-grade lithium and other forms of metal.

The Company’s goal is to quickly enter the lithium market through developing technically uncomplicated, limited environmental footprint projects in Argentina. The Hombre Muerto North Project in Argentina is in a region of lithium production and development. The Salar Escondido Project in Argentina is a drill ready, fully permitted, 29,000 hectare claim block. It represents an exploration opportunity to make a major new lithium discovery.

NRG Metals’ emphasis will be on identifying and establishing a project with the intent of producing an industrial grade lithium product. The Hombre Muerto North Project is a 3,297 Hectare claim package consisting of six concessions in Salta Province. Twenty surface samples collected in 2016-2017 range from 48 to 1,064 mg/L Li, averaging 587 mg/L Li, with seven samples over 800 mg/Li.

NRG Metals has applied for permits, which include exploration test wells, pumping well tests, and evaporation test pond construction. The property package consists of the Alba Sabrina, Tramo, Natalia Maria, Gaston Enrique, Viamonte, and Norma Edit concessions

The Salar Escondido Project is in Catamarca Province, 40km south of Antofagasta de la Sierra. NRG Metals controls a dominant portion of the basin with a total of 29,192 hectares under option. Surface sampling in fresh water zones returned anomalous Li values up to 50ppm and high carbonate values. Preliminary interpretation indicates four distinct zones.

The Salar Escondido Project area is strategically situated within the Lithium Triangle, in close proximity to one of the largest known lithium deposits in Argentina, and within the Puna Region. This region is an elevated plateau that lies on the eastern side of the Andes Mountains. This area contains several highly mineralized salars. This includes the lithium producing salars Hombre Muerto.

Last week, NRG Metals announced that AGV Falcon Drilling SRL (Salta, Argentina) mobilized onto Salar Escondido. It is preparing to start drilling of NRG’s initial drill hole on the property. AGV has wide-ranging experience in the drilling of salar targets in Argentina. This includes the Rincon, Cauchari, and Rio Grande salars.

This week, NRG Metals announced that further to the Company’s news release dated June 5, 2017, it filed a National Instrument 43-101 (NI 43-101) technical report dated September 8, 2017 entitled, “Technical Report for the Hombre Muerto North Project, Salta and Catamarca Provinces, Argentina” The Report was prepared by Montgomery & Associates Consultores Limitada. It was authorized by Mr. Michael J. Rosko, MS PG - an independent Qualified Person under NI 43‑101.

In addition, this week, NRG Metals announced that it entered into a Letter of Intent (LOI) with Chengdu Chemphys Chemical Industry Co., Ltd. (Chemphys) in Chengdu, China, concerning the further exploration and development of the Hombre Muerto North Lithium Project (HMNLP). The LOI also includes a Lithium Offtake Sales Agreement and various other terms. Chemphys specializes in the production of high purity (99.99 percent) Lithium Carbonate and battery grade Lithium Hydroxide for the manufacturing of cathode materials and electrolytes of lithium ion batteries.

NRG Metals, Inc. (NRGMF), closed Friday's trading session at $0.309, up 20.99%, on 1,228,815 volume with 310 trades. The average volume for the last 60 days is 148,221 and the stock's 52-week low/high is $0.07/$0.45.

Protalex, Inc. (PRTX)

Zacks, TopStockAnalysts, StreetInsider, and OTCPicks reported earlier on Protalex, Inc. (PRTX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Protalex, Inc. is a clinical-stage biopharmaceutical company listed on the OTC Markets’ OTCQB. The Company’s concentration is on the development of a class of drugs for treating autoimmune and inflammatory diseases. These include RA (Rheumatoid Arthritis) and ITP (Immune Thrombocytopenia). Its lead product is PRTX-100. This is a formulation of a proprietary, highly purified form of Staphylococcal Protein A, which is an immunomodulatory protein produced by bacteria. Protalex is headquartered in Florham Park, New Jersey.

Rheumatoid arthritis (RA) is an autoimmune disease. RA is a disorder in which the body’s immune system mistakenly attacks the joints. Immune Thrombocytopenia (ITP) is a blood disorder. ITP can result in easy or excessive bleeding and bruising due to the body’s inability to form blood clots.

Pre-clinical data indicate that PRTX-100 may have the potential to treat ITP through reducing the immune-mediated destruction of the platelets. Protalex has open IND’s for the treatment of RA and ITP in the U.S., and in Europe, an open IMPD for ITP.

The Company’s PRTX-100 can (at very low concentrations) bind to human B-lymphocytes and macrophages and to modulate immune processes. PRTX-100 has been granted Orphan Drug Designation in the U.S. and in Europe for the treatment of ITP. This status provides commercial exclusivity benefits, tax credits for certain research, potential research grants and a waiver of the New Drug Application user fee in the United States.

At present, it is the subject of clinical studies in the U.S. and Europe. PRTX-100 is administered as a short intravenous infusion. The following patents have been granted for PRTX-100: U.S. Patent No. 9,370,552 (‘552 patent) is a continuation patent to initial U.S. patent No. 7,211,258 (Protein A compositions and methods of use) filed in 2002 and issued with method of treatment claims for RA, juvenile RA, and systemic lupus erythematosus (SLE). The ‘552 patent expands the method of treatment of PRTX-100 to include type 1 diabetes.

European Patents No. 2,570,136 and 2,206,511 (national patents in place in France, Germany, Italy, Spain, Switzerland, and the UK) includes composition claims relating to many autoimmune diseases (RA, ITP, juvenile RA, psoriasis, myasthenia gravis) and dosage expansion.

Japanese patent No. 5,523,796 claims compositions for treating psoriasis, scleroderma, Crohn’s Disease, myasthenia gravis, ulcerative colitis, psoriatic arthritis, as well as pemphigus vulgaris. Canadian patents No. 2,894,098 and No. 2,481,282 consist of method of treatment claims relating to RA and SLE.

This past August, Protalex announced that the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) awarded Protalex a $403,000 grant to support future clinical development activity of PRTX-100 as a treatment for ITP. The objective of the FDA's OOPD Orphan Products Clinical Trials Grants Program is to encourage the clinical development of new drugs for use in rare diseases or conditions where no present therapy exists, or where the candidate drug will be superior to the existing therapy.

Also in August, Protalex announced that following a planned interim analysis of data from the second dose cohort of its European Phase 1b study of PRTX-100 in adults with persistent/chronic Immune Thrombocytopenia (ITP) (PRTX-100-203 Study), it initiated enrolment in the third cohort of this dose-escalating study. The first patient in the third cohort was dosed at 12.0 µg/kg. This is double that of the second dose cohort of 6.0 µg/kg.

Protalex, Inc. (PRTX), closed Friday's trading session at $0.452, even for the day. The average volume for the last 60 days is 1,076 and the stock's 52-week low/high is $0.312/$3.00.

U.S. Stem Cell, Inc. (USRM)

MarketWatch, TradingView, InvestorsHub, and Money Morning reported on U.S. Stem Cell, Inc. (USRM), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

U.S. Stem Cell, Inc. is a developing enterprise in the regenerative medicine/cellular therapy industry. The Company is a developer of novel autologous cell therapies, and a provider of physician based stem cell therapies to human and animal patients. U.S. Stem Cell has three operating divisions: US Stem Cell Training, Vetbiologics, and US Stem Cell Clinic.

Founded in 1999, U.S. Stem Cell is based in Sunrise, Florida. The Company formerly went by the name Bioheart, Inc. It changed its name to U.S. Stem Cell, Inc. in October of 2015.

U.S. Stem Cell’s emphasis is on the discovery, development, and commercialization of cell based therapeutics that prevent, treat, or cure disease through repairing and replacing damaged or aged tissue, cells and organs and restoring their normal function.

Its lead product candidate is MyoCell®. This is a muscle stem cell therapy intended to improve cardiac function months or even years after a patient has suffered severe heart damage due to a heart attack.

The Company’s business includes the development of proprietary cell therapy products and revenue generating physician and patient based regenerative medicine/cell therapy training services, cell collection and cell storage services, the sale of cell collection and treatment kits for humans and animals, and the operation of a cell therapy clinic.

MyoCell SDF-1 has received approval from the Food and Drug Administration (FDA) to commence human clinical trials. The intention of MyoCell SDF-1 is to be an improvement to MyoCell. Regarding its AdipoCell product, U.S. Stem Cell has applied to the FDA to start trials using adipose derived stem cells or AdipoCell™ in patients with chronic ischemic cardiomyopathy.

This past March, U.S. Stem Cell announced that it developed a strategic alliance with Advanced Stem Cell Rx (ASC) including the development of autologous stem cell treatment centers throughout the U.S. ASC is a U.S. based provider of regenerative medicine programs.

ASC is commercializing many of the proprietary treatments developed by U.S. Stem Cell. ASC is currently implementing turnkey programs into qualified practices throughout the U.S. ASC has contracted with practices in greater than 20 U.S. States.

U.S. Stem Cell has an aggressive plan to expand an additional 12 stem cell treatment centers and clinics in the U.S. The Company is investing and focusing on its in-clinic therapies for patients.

Last week, U.S. Stem Cell announced the publication of a new study, which demonstrates the safety of autologous stem cell therapy in degenerative diseases and injuries. The study, entitled "Safety Analysis of Autologous Stem Cell Therapy in a Variety of Degenerative Diseases and Injuries Using the Stromal Vascular Fraction," is the largest safety trial so far that used stem cells from fat.

The study was published in the Journal of Clinical Medicine Research and co-authored by U.S. Stem Cell Chief Science Officer Kristin Comella, PhD, and Michelle Parlo, PA, Rosemary Daly, DO, Vincent Depasquale, DC, Eric Edgerton, DC, Patrick Mallory, DO, Roy Schmidt, MD, Walter P. Drake, PhD.

U.S. Stem Cell, Inc. (USRM), closed Friday's trading session at $0.0363, up 5.22%, on 1,436,266 volume with 75 trades. The average volume for the last 60 days is 3,967,872 and the stock's 52-week low/high is $0.0016/$0.1793.

Real Goods Solar, Inc. (RGSE)

Stock Twits, MarketWatch, InvestorsHub, Investor Place, Stock News Gazette, Barchart, and TradingView reported on Real Goods Solar, Inc. (RGSE), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Real Goods Solar, Inc.’s RGS Energy operates as a residential and small business commercial solar energy engineering, procurement, and construction company in the U.S. The Company has installed more than 25,000 solar energy systems for homes, businesses, schools, government facilities, and utilities across the nation. This has totaled greater than 260 megawatts of clean energy.

Real Goods Solar (RGS Energy) is headquartered in Denver, Colorado. RGS Energy is the Company’s registered trade name. Established in 1978, RGS Energy was originally incorporated in the State of California in 1982 as Real Goods Trading Corporation. In 2008, the company re-domiciled to Colorado.

The Company is also the exclusive manufacturer of POWERHOUSE™. This is a unique in-roof solar shingle using technology developed by The Dow Chemical Company. RGS Energy has entered into an exclusive domestic and global license agreement with The Dow Chemical Company for the POWERHOUSE™ solar shingles system. RGS will lead all commercial activities for the product. This includes supply chain management, marketing, sales, installation, and warranty.

This solar shingle system has been deployed on more than 1,000 homes. RGS Energy and Dow Chemical anticipate UL product certification during Q1 of 2018. Pre-orders are being taken in advance of final written certification. RGS Energy’s plan is to commence sales and installation of POWERHOUSE™ 3.0 solar shingles immediately after.

Last week, RGS Energy announced that it has been chosen by Solarize New Haven to bring solar electricity to homes and business owners in New Haven, Connecticut. Solarize New Haven is a community-based residential solar purchasing cooperative.

Mr. Tom Champlin, Director of Sales at RGS Energy, said, “We are thrilled to be joining forces with Solarize Connecticut once again for what we believe will be another successful Solarize program. We will provide our exceptional service to New Haven, supported by our 31 local Connecticut employees, based out of our 10,000 square foot, centrally located, warehouse in Bloomfield.”

Regarding RGS Energy’s business segments, the Solar Division comprises RGS Energy’s Residential and Sunetric business segments. The Corporate segment includes administrative costs associated with administrative services, legal settlements, legal, information systems, and accounting and finance. Starting on September 29, 2017, POWERHOUSE™ is the Company’s new business segment.

RGS Energy markets its products and services via an outside sales team, inside sales, e-sales, customer referral programs, and alliances and channel partnerships. It also markets its products and services by way of an online direct marketing channel.

Real Goods Solar, Inc. (RGSE), closed Friday's trading session at $2.23, down 5.11%, on 1,009,945 volume with 2,228 trades. The average volume for the last 60 days is 1,940,792 and the stock's 52-week low/high is $0.6001/$67.80.

Innovus Pharmaceuticals, Inc. (INNV)

PennyPickAlerts, Fortune Stock Alerts, BUYINS.NET, Penny Stock Bets, StockMister, SeeThruEquityResearch, Promotion Stock Secrets, TopPennyStockMovers, DSR News, Penny Stock Hub, PHUB News, Wall Street Mover, HotTopPennyStocks, StockMarketQuote.us, Penny Stock Circle, 1-2-3 Stock Alerts, and OTPicks reported on Innovus Pharmaceuticals, Inc. (INNV), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Innovus Pharmaceuticals, Inc. is a developing Over-The-Counter (OTC) consumer goods and specialty pharmaceutical company. It engages in the commercialization, licensing, and development of safe and effective non-prescription medicine and consumer care products to improve men’s and women’s health and vitality and respiratory diseases. Innovus Pharmaceuticals is headquartered in San Diego, California. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Innovus Pharmaceuticals generates revenues from its lead products BTH® Testosterone Booster; BTH® Human Growth Agent; Zestra® for female arousal and EjectDelay® for premature ejaculation. The Company has plans to enter the oncology supportive care OTC market with an exclusive license to two GRAS (Generally Recognized As Safe by the U.S. FDA)-listed compounds, thymol and carvacrol, for cachexia and muscle growth and repair, from the University of Iowa Research Foundation.

The Company has an additional five marketed products. These include Sensum+® for the indication of reduced penile sensitivity; Zestra Glide®; Vesele® for promoting sexual health; RecalMax™ for promoting brain and cognitive health; Androferti® (in the U.S. and Canada) to support overall male reproductive health and sperm quality; BTH Vision Formula; BTH Blood Sugar, among others and eventually FlutiCare™ OTC for Allergic Rhinitis, if Innovus’ Abbreviated New Drug Application (ANDA) receives approval by the Food and Drug Administration (FDA).

Innovus Pharmaceuticals markets its products in the U.S. and Canada via retailers and on the web. Additionally, it details its products to urologists, gynecologists, and sex therapists. It does so either directly in the U.S. or through commercial partners globally.

Innovus Pharmaceuticals has initiated a pre-clinical and clinical program intended to evaluate the safety and efficacy of the combination of its supplement Vesele® for promoting sexual health with sildenafil indicated for treating erectile dysfunction. Sildenafil in the U.S. is sold under the name Viagra® by Pfizer, Inc.

Vesele® is a proprietary oral formulation of L-Arginine and L-Citrulline with the natural absorption enhancer Bioperine®. Vesele® was formulated to increase blood flow and nitric oxide production.

Innovus announced earlier this year the launch of AllerVarx™ in the U.S. AllerVarx™ is a clinically proven supplement, scientifically formulated for the relief of allergy symptoms. AllerVarx™, selling in Europe under the brand name Lertal®, is a product Innovus Pharmaceuticals exclusively in-licensed for the U.S. and Canada from NTC s.r.l. - an Italian company.

This week, Innovus Pharmaceuticals announced that it received approval from Health Canada to market its best-selling, clinically proven Vesele® product as a Natural Health Product (NHP) to help improve nitric oxide production involved in symptoms of sexual dysfunction. Vesele® will be available over-the-counter (OTC) in 120 capsule bottles in Canada.

Vesele® will not require a prescription. The product will not be reimbursed by the Canadian government. As a result, Innovus Pharmaceuticals will be able to set the retail price as it does in the U.S.

Innovus Pharmaceuticals, Inc. (INNV), closed Friday's trading session at $0.087, even for the day, on 228,378 volume with 20 trades. The average volume for the last 60 days is 418,999 and the stock's 52-week low/high is $0.082/$0.39.

graphic

The QualityStocks
Company Corner

graphic
graphic

MGX Minerals Inc. (MGXMF)

The QualityStocks Daily Newsletter would like to spotlight MGX Minerals Inc. (MGXMF). Today, MGX Minerals Inc. closed trading at $0.80995, up 2.53%, on 419,300 volume with 154 trades. The stock’s average daily volume over the past 60 days is 98,560 and its 52-week low/high is $0.11/$2.119.

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring MGX Minerals Inc. (CSE: XMG) (FRANKFURT: 1MG) (OTCQB: MGXMF), a client of NNW that operates as a diversified Canadian resource company developing large-scale mineral portfolios in specific commodities and jurisdictions in North America. The publication, titled, "World Demand for Lithium Growing Rapidly as Energy Storage Needs Skyrocket," shines a light on the push for electric vehicles, and the various companies set on meeting the growing demand for lithium. To view the full publication, visit: https://www.networknewswire.com/world-demand-lithium-growing-rapidly-energy-storage-needs-skyrocket/ 

MGX Minerals Inc. (CSE: XMG) (FKT: 1MG) (OTCQB: MGXMF) is a diversified Canadian resource company developing large-scale mineral portfolios in specific commodities and jurisdictions in North America. The company controls significant interest in lithium, magnesium and silicon assets that offer streamlined development timelines and low capital expenditures. MGX Minerals and its engineering partner have developed a patent-pending, low-energy design process to extract valuable minerals from the abundant, highly mineralized brine wastewater produced each year by oil and gas companies.

This proprietary, petrolithium process rapidly concentrates lithium and other minerals from brine in less than a day. That's a stunning advancement from the conventional method of extracting minerals from brine through an evaporation process that can take up to 18 months, requires hundreds of acres of land, and averages less than a 50 percent mineral recovery rate. Using this advanced water purification technology, MGX Minerals cleans the wastewater that accompanies petroleum as it's being pulled up to the surface. The company's petrolithium process eliminates the need to inject contaminated wastewater back into the ground, which prevents drinking water contamination and possible earthquakes.

In January 2017, MGX Minerals successfully recovered concentrated lithium from heavy oil evaporator blowdown wastewater using its rapid recovery process, an accomplishment independently confirmed by the Saskatchewan Research Council. In August 2017, the company also successfully processed wastewater and lithium brine from eight North American projects at its one-cubic-meter-per-hour processing plant, proving the technology is economically viable. Research group Global Water Intelligence expects the wastewater treatment industry to grow into a $45 billion market annually by 2025, which suggests there are ample revenue-generating opportunities for MGX Minerals technology.

Lithium, the "white gold" of the new energy economy, is the key to clean energy development as global demand for hybrid and electric vehicles, high-drain portable electronic devices, and large-scale energy storage systems ramps up. Grand View Research, Inc. reports that the global lithium-ion battery market is expected to reach $93.1 billion by 2025. Current market forces show a high demand for lithium and a low supply, which further supports the necessity of MGX Mineral's cleaner, faster method of extracting high-value minerals from brine wastewater.

MGX Minerals is led by a team of industry standout performers who have worked in the mining and technology industries for decades. The leadership team is joined by an array of top-notch technical partners with unmatched experience in the oil and gas sectors, environmental services industry, marketing and product development, along with applied research and commercial development of technologies. Disclaimer

MGX Minerals Inc. Blog

MGX Minerals Inc. News:

NetworkNewsWire Announces Publication on Public Companies Racing to Meet Swelling Global Demand for Lithium

MGX Minerals Processes High Magnesium Content Lithium Brine of 76,000mg/L Mg; Nears Completion of First Commercial Rapid Lithium Extraction System

MGX Minerals Appoints Mining Executive Ian Graham as VP Operations

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE). Today, Global Payout, Inc. closed trading at $0.0198, up 2.86%, on 801,231 volume with 46 trades. The stock’s average daily volume over the past 60 days is 2,968,204, and its 52-week low/high is $0.0077/$0.04.

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Global Payout, Inc. (OTC: GOHE), a client of NNW that provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The publication, titled, "Standout Players Find Varied, Innovative Means of Serving the Marijuana Industry," discusses companies offering innovative service solutions to the diverse cannabis industry. To view the full publication, visit: https://www.networknewswire.com/standout-players-find-varied-innovative-means-serving-marijuana-industry/

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout's fully configurable "banking-in-a-box" web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today's banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout's management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and "high-risk" market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and "high-risk" enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions. Disclaimer

Global Payout, Inc. Company Blog

Global Payout, Inc. News:

NetworkNewsWire Announces Publication Discussing the Diverse Services of Innovative Cannabis Stocks

Global Payout’s MoneyTrac Technology, Inc. Successfully Expands Brand Awareness with Presence at the 2017 Southwest Cannabis Conference and Expo

Global Payout’s MoneyTrac Technology, Inc. Enters Final Stages of Revenue-Generating Joint Venture Partnership with Established Financial Institution to Deliver Banking Solutions to the Cannabis Industry

Greenkraft, Inc. (GKIT)

The QualityStocks Daily Newsletter would like to spotlight Greenkraft, Inc. (GKIT). Today, Greenkraft, Inc. closed trading at $0.1026, up 14.00%, on 26,000 volume with 6 trades. The stock’s average daily volume over the past 60 days is 13,781 and its 52-week low/high is $0.019/$0.20.

Greenkraft, Inc. (GKIT) is a nationally recognized company specializing in the production of alternative fuel automotive products, including engines and commercial trucks. Located in Santa Ana, California, the company's mission is to provide clean, green, energy efficient automotive products that have a price advantage coupled with unparalleled American performance. Established in 2008, Greenkraft, Inc. serves the commercial truck market powered by the alternative fuels CNG and LPG in classes 4, 5, 6 and 7.

Greenkraft's new line of trucks, known as the G3 and G4, will accommodate weights of 26,000 lbs. and 33,000 lbs., respectively. George Gemayel, CEO of Greenkraft, Inc., said the demand for larger trucks that run on alternative fuels continues to increase.

"Greenkraft is going to revolutionize the trucking industry with these new 26,000 and 33,000 lbs. trucks that run on CNG and PROPANE fuel," Gemayel states in a press release. "The only way we can meet increased demand for Greenkraft products is to expand our current factory. This expansion is one of many factors that will substantially increase the Company's revenue in 2017."

Greenkraft produces a cab forward design for its commercial trucks, which allows the passenger area to be much larger than in other similar sized vehicles. Several tank capacity options exist, making it easy to select the most efficient model for a client's specific needs. Greenkraft is one of the only companies in the world to offer a refrigeration option with an alternative fuel truck – an essential, must-have option for many businesses.

Greenkraft trucks, considered among the best performing in the heavy-duty market, are used in a variety of industries and in some of the nation's largest cities. The company also offers a line of trucks designed to run with a package from Allison Transmission Holdings, Inc. (NYSE: ALSN), which gives clients the option of purchasing a fully automatic transmission vehicle. This option expands the size of the driver pool since fully automatic shifting reduces driver fatigue, contributes to solving the issue of driver retention, and it is easy to use.

CNG and LPG conversion systems made by Greenkraft are available for several major automobile brands including Ford, GM and Isuzu/GM. Installation, service, parts and warranty are all available through Greenkraft facilities and its partners. Disclaimer

Greenkraft, Inc. Blog

Greenkraft, Inc. News:

Greenkraft, Inc.'s (GKIT) Alternative Fuel Engine Awarded Certification for Exceeding California's Clean Air Act Standards

Greenkraft, Inc. Expands Distribution Network to Meet Increased Product Demand

Greenkraft, Inc. (GKIT) Engages NetworkNewsWire for Corporate Communications Solutions

Tapinator, Inc. (TAPM)

The QualityStocks Daily Newsletter would like to spotlight Tapinator, Inc. (TAPM). Today, Tapinator, Inc. closed trading at $0.18, up 12.50%, on 144,208 volume with 31 trades. The stock’s average daily volume over the past 60 days is 62,625 and its 52-week low/high is $0.0711/$0.2419.

Tapinator, Inc. (TAPM) is a developer and publisher of mobile games on the iOS, Google Play and Amazon platforms. The Company's portfolio includes over 300 mobile gaming titles generating hundreds of thousands of daily player downloads that provide predictable and attractive returns through the sale of branded advertisements and consumer app store transactions. Tapinator, based in New York and with product development teams located throughout the world, was founded in 2013 by a visionary team that has been building mobile games and applications since 2007 and has achieved multiple successful exits.

Tapinator's business strategy includes the creation of a select number of best-in-class Full-Featured Games, such as ROCKY™ and Solitaire Dash, which provide game players with more in-depth, unique content that supports long-term retention and generates higher investment returns. The Full-Featured Games model creates the potential for sustainable $100+ million franchise-type games that have product lifespans of at least five years. Tapinator uses a proprietary set of dynamic development and marketing processes factored upon gaming category, estimated player retention and projected player profitability.

Recent successful launches of two new Full-Featured titles – Big Sport Fishing 2017 and Dice Mage 2 – were recognized on the Apple iOS platform as "New Games We Love." During the game's first seven days after global release, Big Sport Fishing 2017 received well over 520,000 player downloads. Four new titles, ColorFill, Divide & Conquer, Shadowborne and Fusion Heroes, are in the pipeline for release in Q4 2017 and Q1 2018 as well. The formula for these game combines proven gameplay elements with best-in-class monetization systems, supplemented by Tapinator's strong creative team of developers, strategists and product specialists. The company's Rapid-Launch Games division also saw increasing player interest recently with the launch of Fidget Spinner Superhero and Scary Shark Evolution 3D.

Tapinator's diversified revenue sources includes 54 percent from advertising placed within its mobile games and 46 percent from consumer app store purchases. The Company limits advertising placements to between game levels and also runs rewarded video ad units that are tied directly into the game's currency. Tapinator's portfolio includes more than 300 active titles, with no single game accounting for more than 25 percent of total revenues during the first half of 2017.

As Tapinator looks toward the future, opportunities in Virtual Reality (VR) and Augmented Reality (AR) show great promise. The company has released several prototype VR games to gather data before pursuing a more significant VR product. Recent market reports suggest that the VR industry will hit $30 billion by 2020 and the AR industry will surpass that with a projected $120 billion. Tapinator also plans to pursue publishing transactions that leverage its network, platform relationships and operational excellence. Significant opportunities for expanding Tapinator's gaming IP to new platforms such as Steam and leading messaging apps are also on the horizon. The company is targeting a 30+ percent annual bookings growth target for 2017-2019. Disclaimer

Tapinator, Inc. Blog

Tapinator, Inc. News:

NetworkNewsWire Announces Publication Discussing Competitive Companies in the Global Gaming Market

Tapinator Announces Major Update of Hit Game Dice Mage 2

Tapinator, Inc. (TAPM) is “One to Watch”

AppSwarm, Inc. (SWRM)

The QualityStocks Daily Newsletter would like to spotlight AppSwarm, Inc. (SWRM). Today, AppSwarm, Inc. closed trading at $0.0129, up 29.00%, on 133,110 volume with 8 trades. The stock’s average daily volume over the past 60 days is 141,763 and its 52-week low/high is $0.002/$0.04.

AppSwarm, Inc. (SWRM) is a technology development and incubation acceleration company that partners up with developers through joint ventures, royalty agreements, marketing partnerships, and outright purchase agreements. Focusing on the ever-growing mobile applications market, the company provides all the resources needed for engagement, retention, virality and monetization.

The global games market generated approximately $100 billion in revenues in 2016, but large global game companies have made it extremely difficult for smaller developers to achieve success in the marketplace. As a result, many great ideas aren't monetized. AppSwarm solves this problem by providing the funding and critical business expertise needed to successfully launch and market new applications.

Business applications is another area of focus for the company. Targeting small to medium sized businesses, AppSwarm will be developing and acquiring mobile application tools and platforms that increase productivity and security via data encryption, cloud storage, content management and delivery, digital payments, automation, and customer loyalty marketing solutions. Recent acquisitions made so far represent only a small example of future planned initiatives to develop and market tools for the business community.

Regardless of the target market, AppSwarm can help developers accelerate the success of their app through funding, technology and marketing expertise, as well as a unique eco system that accelerates user acquisition. The company is able to assist at any state of development with completion of concept, market analysis, business and financial management, direct sales and marketing, social game development to ensure correct product application and expedient deployment with cost efficiency.

Ron Brewer, CEO of the company, has accumulated extensive leadership in the technology sector and brings valuable knowledge gained as a Director of Southbridge Advisory Group for nearly 20 years. Ron's C-level experience includes merger & acquisition and post-acquisition turnaround in both the private and small-cap public sector. John Rabbit, director of finance, is a seasoned business veteran that has worked with Fortune 500 firms and served in CEO, COO and CFO positions for firms ranking from $5 million to $300 million in annual revenues. John was directly involved in numerous acquisitions and served in executive capacities for several multinational subsidiaries.

With a well-suited management team, multiple synergistic revenue streams, and diversified growth strategy, AppSwarm is well positioned in a steadily growing industry with countless opportunities for capitalization. Disclaimer

AppSwarm, Inc. Blog

AppSwarm, Inc. News:

AppSwarm, Inc. Announces Joint Venture with Last-Mile Delivery Firm Estorerunner

AppSwarm, Inc. is Developing Last-Mile Delivery Application Management Platform

NetworkNewsWire Releases Exclusive Audio Interview with AppSwarm, Inc. (SWRM)

92 Resources Corp. (TSX.V:NTY) (OTCQB:RGDCF) (FSE:R9G2)

The QualityStocks Daily Newsletter would like to spotlight 92 Resources Corp. (RGDCF). Today, 92 Resources Corp. closed trading at $0.081, up 6.58%, on 16,300 volume with 5 trades. The stock’s average daily volume over the past 60 days is 24,080 and its 52-week low/high is $0.071/$0.1318.

92 Resources Corp. (TSX.V: NTY) (OTCQB: RGDCF) is a modern energy solutions company focused on acquiring and advancing strategic and prospective energy-related projects in Canada. Its three principal assets include the Hidden Lake Lithium Property in the Northwest Territories, the Pontax Lithium Property in Quebec, and the Golden Frac Sand Property in British Columbia.

Preliminary mineralogy work on samples taken of the Hidden Lake pegmatites indicate spodumene – the world's richest source of lithium – is of a high quality and near the maximum theoretical limit. Scoping testwork saw an overall lithium extraction of 97 percent from the concentrate produced from these pegmatites, which means standard lithium extraction techniques can be applied, making the extraction of lithium easier and more cost effective.

92 Resources is focused on developing the lithium-rich resources located within its properties through open-pit mining and relatively straight-forward mineral processing procedures. Surface exploration programs that include prospecting, mapping and sampling of known spodumene-bearing pegmatites on the Hidden Lake property suggests the existence of one massive, interconnected body of pegmatite below the surface. Recent acquisitions of prospective hard-rock lithium properties in Quebec add to the company's impressive and growing asset portfolio.

Recent acquisitions of prospective hard-rock lithium properties in Quebec add to the company's impressive and growing asset portfolio. The properties, known as Corvette, Eastmain and Lac Du Beryl, consist of a combined 115 mineral claims totaling approximately 14,710 acres with confirmed pegmatite outcrops visible at each location. Some sampling has been completed at the Corvette property and shows spodumene crystals present, making this location a high priority for follow up work. Analytical results are pending on samples taken from known pegmatite outcrops visible at each property.

Lithium is a strategic, green metal used in batteries, electronics, electric vehicles, ceramics, alloys, lubricants and pharmaceuticals. The world market for electric vehicles, with China as its biggest customer, is exponentially growing as the demand for clean, renewable energy sources increases. A recent report by Grand View Research, Inc. places the lithium-ion battery market worldwide at $93 billion by 2025, with a compound annual growth rate of 17%.

92 Resources is led by an experienced management team and advisors with decades of expertise in market strategies, corporate development, mineral exploration and energy development. With an excellent team of professionals and promising mining projects, the company is well positioned to capitalize on the ever-rising demand for lithium. Disclaimer

92 Resources Corp. Blog

92 Resources Corp. News:

NetworkNewsWire Announces Publication Discussing the Impact of Lithium Demand on Several Public Companies

Lithium, Fuelling the New Millennium

92 Resources Corp. Acquires Three New Properties in Quebec

ChineseInvestors.com, Inc. (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com, Inc. (CIIX). Today, ChineseInvestors.com, Inc. closed trading at $0.54, off by 0.92%, on 182,411 volume with 54 trades. The stock’s average daily volume over the past 60 days is 103,951 and its 52-week low/high is $0.36/$2.75.

Founded in 1999, ChineseInvestors.com, Inc. (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world's first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer's disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX's cannabis-focused "Yelp"-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. Disclaimer

ChineseInvestors.com, Inc. Blog

ChineseInvestors.com, Inc. News:

ChineseInvestors.com, Inc. Launches Bitcoin Multimillionaire, the First Daily Video Cryptocurrency Newscast in the Chinese Language, With Plans to Launch a New Cryptocurrency Website Under the Domain 'newcoin168.com'

SeeThruEquity Issues Update on ChineseInvestors.com Inc. (OTCQB: CIIX)

ChineseInvestors.com, Inc. Appoints Skin Care Industry Veteran and Shanghai Beauty Influencer, Fannie Tang, as Marketing Director of its Wholly-owned Foreign Enterprise, CBD Biotechnology Co., Ltd.

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

Monster Alerts
(PMSO) +350.00%

2.

Barchart
(SKX) +41.45%

3.

QualityStocks
(SWRM) +29.00%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251